Growth factors and hemostasis: Differential effects of GM-CSF and G-CSF on coagulation activation - Laboratory and clinical evidence

Annals of Hematology

Volumn 80, Issue 9, 2001, Pages 525-530

  Bonig H ^a   Burdach, S ^b   Gobel U ^a   Nurnberger W ^a,c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Division of Pediatrics   (Germany)

Author keywords

Bone marrow transplantation; Granulocyte colony stimulating factor; Granulocyte macrophage colony stimulating factor; Hemostasis; Veno occlusive disease of the liver

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITHROMBIN; ATENATE; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; CARBOPLATIN; ETOPOSIDE; FIBRINOGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; HEMOPOIETIC GROWTH FACTOR; MELPHALAN; MYELOABLATIVE AGENT; PLASMA PROTEIN; PLASMINOGEN ACTIVATOR DERIVATIVE; PROTEIN C; PROTHROMBIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOPLASTIN; VITAMIN K GROUP;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING PARAMETERS; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEMATOPOIETIC STEM CELL; HEMOSTASIS; HUMAN; LABORATORY TEST; LIVER VENOOCCLUSIVE DISEASE; MALE; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; THROMBOSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOSTASIS; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INFANT; MALE; MYELOABLATIVE AGONISTS; PROSPECTIVE STUDIES;

EID: 0034800025     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770100349     Document Type: Article

References (27)

1. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on circulating platelets
2. Reduction of plasma fibrinolytic activity following high-dose cyclophosphamide is neutralized in vivo by GM-CSF administration
3. Myeolablative chemo-radiotherapy and hematopoietic stem cell rescue in poor prognosis Ewing's sarcoma
4. In vitro and in vivo activation of endothelial cells by colony-stimulating factors
5. Plasminogen activator in granulocyte-macrophage-CSF transgenic mice
6. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor
7. Granulocyte-colony stimulating factor inhibits TNFalpha production in a human hepatoma cell line
8. Factors predicting morbidity following hematopoietic stem cell transplantation
9. Granulocyte-macrophage colony stimulating factor (rhGM-CSF) in the treatment of chemotherapy-induced neutropenia
10. Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma
11. G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation
12. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells
13. Veno-occlusive disease of the liver following bone marrow transplantation
14. Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor
15. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production
16. Enhancement of plasminogen activator activity in cultured endothelial cells by granulocyte colony-stimulating factor
17. Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers
18. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoma
19. Subretinal haemorrhage after granulocyte colony stimulating factor
20. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity
21. Analysis of rhG-CSF-effects on platelets by in vitro bleeding test and transcranial Doppler ultrasound examination
22. Granulocyte macrophage colony stimulating factor: High incidence of apheresis catheter thrombosis during peripheral stem cell collection
23. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release
24. Arterial thrombosis associated with granulocytemacrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: A report of two cases
25. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model
26. Clinical toxicity of cytokines used as haemopoietic growth factors
27. Induction of endothelial cell/macrophage procoagulant activity: Synergistic stimulation by gamma interferon and granulocyte-macrophage colony stimulating factor